As part of our broader development, Sever Pharma Solutions AB is changing its name to QPharma AB, effective September 1, 2026, strengthening the visibility of an established and well-recognized name.
Read more
Sever Pharma Solutions (SPS) is pleased to announce the appointment of Erik Hensfelt as General Counsel, effective February 1, 2026
Read more
We are pleased to announce the appointment of Niklas Lindgren as the company’s new Vice President of Quality, effective January 19, 2026.
Read more
We are pleased to announce the appointment of Linda Rebert as its new VP Operations, effective December 1, 2025.
Read more
We are proud to celebrate our 50th anniversary this year. The milestone marks five decades of innovation, expertise, and partnership in pharmaceutical development and manufacturing.
Read more
We are pleased to announce the appointment of Malin Wendt as the new Supply Chain Management Director, effective September 1st, 2025.
Read more
Sever Pharma Solutions is pleased to announce the publication of its Sustainability Report 2024, highlighting our ongoing commitment to responsible business practices and sustainable growth.
Read more
Sever Pharma Solutions has made an expanded agreement with Silo Pharma, Inc. (Nasdaq: SILO).
Read more
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
Read more
06 – 08 October, 2026
Milan, Italy
CPHI - Stand: 10H50
